0
0
A recent study from Northwestern Medicine reveals that Human Pegivirus (HPgV), a virus previously considered harmless, may play a role in Parkinson’s disease, a neurodegenerative disorder affecting over one million Americans. This discovery challenges longstanding assumptions about the virus and opens new avenues for understanding Parkinson’s disease development.
Key Findings and Developments
Researchers detected HPgV in the brains and spinal fluid of Parkinson’s patients but not in people without the disease. Analysis of post-mortem brain tissue from 10 Parkinson’s patients found the virus in five of them, while none of the 14 control brains showed its presence. The virus’s presence in spinal fluid suggests activity within the nervous system. Moreover, Parkinson’s patients carrying HPgV exhibited more advanced brain changes typical of the disease, including protein buildup and altered brain chemistry.
Using blood samples from over 1,000 participants, researchers identified immune system changes linked to HPgV. Notably, patients with a Parkinson’s-related LRRK2 gene mutation responded differently to the virus, hinting at an interaction between genetic and environmental factors in disease progression. Dr. Igor Koralnik, chief of neuroinfectious diseases at Northwestern, stated, “It may influence how Parkinson’s develops, especially in people with certain genetic backgrounds.” These findings were published in the peer-reviewed journal JCI Insight.
Expert Commentary and Context
Dr. Joel Salinas, a behavioral neurologist at NYU Grossman School of Medicine who was not involved in the study, emphasized caution, noting the early stage of this research. He stated, “This raises the possibility of a link between viral exposure and Parkinson’s, but it’s far too early to say the virus causes the disease.” Salinas highlighted the need for larger and longer-term studies to determine clinical significance and drew comparisons with prior research on herpesviruses and Alzheimer’s disease, where viral associations remain tentative.
Parkinson’s disease is the second most common brain disorder after Alzheimer’s, with about 90,000 new cases diagnosed annually in the U.S. The exact cause remains largely unknown, particularly as most patients do not have a family history of the disease. The discovery of HPgV’s frequent presence only in Parkinson’s patients suggests potential new explanations for why some individuals develop the disease and others do not.
Implications for Public Health and Practical Takeaways
If later studies confirm HPgV’s involvement in Parkinson’s, this could revolutionize how the disease is understood and treated. Targeting viral infections or modulating the immune response could become future therapeutic strategies. Meanwhile, people should not be alarmed or change health behaviors based on current findings, which remain preliminary. Awareness of interactions between genetics and environmental factors like viral exposures can inform ongoing research into Parkinson’s prevention and management.
Limitations and Balanced Perspectives
The study’s small sample size—just 10 Parkinson’s brains and 14 controls—limits definitive conclusions. Absence of the virus in controls is notable but requires validation in larger cohorts. The virus’s role could be contributory rather than causal, necessitating nuanced interpretation. The presence of HPgV in Parkinson’s brains also does not confirm it triggers or worsens the disease; it may be a marker or consequence of other pathological processes.
Conclusion
This pioneering research challenges the assumption that HPgV is a benign infection, revealing its unexpected presence in Parkinson’s patients’ brains and suggesting interaction with genetic factors. Though far from definitive, the findings underscore the importance of exploring viral and immune mechanisms in neurodegenerative diseases. Continued investigation may illuminate new pathways for understanding and eventually treating Parkinson’s disease.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
-
Koralnik I, et al. Human Pegivirus found in Parkinson’s disease brains and cerebrospinal fluid. JCI Insight. 2025; https://www.foxnews.com/health/harmless-virus-found-lurking-parkinsons-patients-brains-new-study-shows
